ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

KLTOW Klotho Neurosciences Inc

0.038501
-0.0064 (-14.25%)
Last Updated: 09:34:55
Delayed by 15 minutes

Period:

Draw Mode:

Volume 442
Bid Price 0.04
Ask Price 0.0498
News -
Company Name Stock Ticker Symbol Market Type
Klotho Neurosciences Inc KLTOW NASDAQ Equity Warrant
  Price Change Change Percent Stock Price Last Traded
-0.0064 -14.25% 0.038501 09:34:55
Open Price Low Price High Price Close Price Prev Close
0.04415 0.038501 0.04415 0.0449
Trades Volume VWAP Dollar Volume Avg Volume
4 442  0.04415  20 -
Last Trade Time Type Quantity Stock Price Currency
11:00:17 21  0.0401 USD

Klotho Neurosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
152.88k 3.41M - 0 1.35M 0.40 5.92
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Klotho Neurosciences

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No KLTOW Message Board. Create One! See More Posts on KLTOW Message Board See More Message Board Posts

KLTOW Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Klotho Neurosciences, Inc. (NASDAQ: KLTO), a biopharmaceutical company specializing in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders. The Company obtained exclusive worldwide rights to platform technologies and knowhow to develop cutting edge protein, gene and cell therapies to treat age-related pathologies such as ALS, Alzheimer's and Parkinson's Disease, multiple sclerosis and rare neurodegenerative diseases. The company's current portfolio consists of its proprietary gene therapy program using DNA and RNA as therapeutics and diagnostics. Other assets include clinical-stage programs involving antibody biologics targeting cancer and autoimmune diseases, and drug delivery via a needle-free dry powder jet autoinjector called Nanoject.

NASDAQ:KLTOW -

What is the current Klotho Neurosciences Inc share price?
The current share price of Klotho Neurosciences Inc is $ 0.038501
How many Klotho Neurosciences Inc shares are in issue?
Klotho Neurosciences Inc has 3,405,000 shares in issue
What is the market cap of Klotho Neurosciences Inc?
The market capitalisation of Klotho Neurosciences Inc is USD 152.88k
What is the 1 year trading range for Klotho Neurosciences Inc share price?
Klotho Neurosciences Inc has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Klotho Neurosciences Inc?
The price to earnings ratio of Klotho Neurosciences Inc is 5.92
What is the reporting currency for Klotho Neurosciences Inc?
Klotho Neurosciences Inc reports financial results in USD
What is the latest annual profit for Klotho Neurosciences Inc?
The latest annual profit of Klotho Neurosciences Inc is USD 1.35M
What is the registered address of Klotho Neurosciences Inc?
The registered address for Klotho Neurosciences Inc is 131 CONTINENTAL DRIVE SUITE 305, NEW CASTLE, NEWARK, DELAWARE, 19713
Which industry sector does Klotho Neurosciences Inc operate in?
Klotho Neurosciences Inc operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Your Recent History

Delayed Upgrade Clock